Supplemental material
Journal of Medical Economics
Volume 25, 2022 - Issue 1
Oncology
The impact of remission duration on the long-term economic burden of acute myeloid leukemia among patients without hematopoietic stem cell transplant in the United States
Ashley Tabaha Bristol Myers Squibb, Princeton, NJ, USA
https://orcid.org/0000-0003-3754-2703
https://orcid.org/0000-0003-3754-2703, Brenna L. Bradyb IBM Watson Health, Cambridge, MA, USACorrespondence[email protected]
https://orcid.org/0000-0003-3210-806X
https://orcid.org/0000-0003-3210-806X, David Huggara Bristol Myers Squibb, Princeton, NJ, USAhttps://orcid.org/0000-0002-9037-8140
https://orcid.org/0000-0002-9037-8140, , , & Thomas William LeBlancc Duke Cancer Institute, Durham, NC, USAhttps://orcid.org/0000-0002-0546-7895
https://orcid.org/0000-0002-0546-7895 show all